Vertebrate scavenger receptor class B member 2 (SCARB2): comparative studies of a major lysosomal membrane glycoprotein

Roger Stephen Holmes

Abstract


Scavenger receptor class B member 2 (SCARB2) (also LIMP-2, CD36L2 or LGP85) is a major lysosomal membrane glycoprotein involved in endosomal and lysosomal biogenesis and maintenance. SCARB2 acts as a receptor for the lysosomal mannose-6-phosphate independent targeting of β-glucuronidase and enterovirus 71 and influences Parkinson’s disease and epilepsy. Genetic deficiency of this protein causes deafness and peripheral neuropathy in mice as well as myoclonic epilepsy and nephrotic syndrome in humans. Comparative SCARB2 amino acid sequences and structures and SCARB2 gene locations were examined using data from several vertebrate genome projects. Vertebrate SCARB2 sequences shared 43-100% identity as compared with 30-36% sequence identities with other CD36-like superfamily members, SCARB1 and CD36. At least 10 N-glycosylation sites were conserved among most vertebrate SCARB2 proteins examined. Sequence alignments, key amino acid residues and conserved predicted secondary structures were examined, including cytoplasmic, transmembrane and external lysosomal membrane sequences: cysteine disulfide residues, thrombospondin (THP1) binding sites and 16 proline and 20 glycine conserved residues, which may contribute to short loop formation within the exomembrane SCARB2 sequences. Vertebrate SCARB2 genes contained 12 coding exons. The human SCARB2 gene contained a CpG island (CpG100), ten microRNA-binding sites and several transcription factor binding sites (including PPARA) which may contribute to a higher level (2.4 times average) of gene expression. Phylogenetic analyses examined the relationships and potential evolutionary origins of the vertebrate SCARB2 gene with vertebrate SCARB1 and CD36 genes. These suggested that SCARB2 originated from duplications of the CD36 gene in an ancestral genome forming three vertebrate CD36 gene family members: SCARB1, SCARB2 and CD36.


Keywords


Vertebrates; SCARB2; comparative proteomics; comparative genomics; evolution; thrombospondin receptor

References


Acton S, Osgood D, Donoghue M, Corella D, Pocovi M, Cenarro A, Mozas P, Keilty J, Squazzo S, Woolf EA & Ordovas JM 1999 Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 19 1734-1743.

Adachi H & Tsujimoto M 2006 Endothelial scavenger receptors. Prog Lipid Res 45 379-404.

Akasaki K, Suenobu M, Mukaida M, Michihara A & Wada I 2010 COOH-terminal isoleucine of lysosome-associated membrane protein-1 is optimal for its efficient targeting to dense secondary lysosomes. J Biochem 148 669-679.

Altschul F, Vyas V, Cornfield A, Goodin S, Ravikumar TS, Rubin EH & Gupta E 1997 Basic local alignment search tool. J Mol Biol 215 403-410.

Balreira A, Gaspar P, Caiola D, Chaves J, Beirão I, Lima JL, Azevedo JE & Miranda MC 2008 A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome. Hum Mol Genet 17 2238-2243.

Bartel DP 2009 MicroRNAs: target recognition and regulatory functions. Cell 136 215-233.

Bentley AA & Adams JC 2010 The evolution of thrombospondins and their ligand-binding activities. Mol Biol Evol 27 2187-2197.

Berkovic SF, Dibbens LM, Oshlack A, Silver JD, Katerelos M, Vears DF, Lüllmann-Rauch R, Blanz J, Zhang KW, Stankovich J, Kalnins RM, Dowling JP, Andermann E, Andermann F, Faldini E, D'Hooge R, Vadlamudi L, Macdonell RA, Hodgson BL, Bayly MA, Savige J, Mulley JC, Smyth GK, Power DA, Saftig P & Bahlo M 2008 Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am J Hum Genet 82 673-684.

Blanz J, Groth J, Zachos C, Wehling C, Saftig P & Schwake M 2010 Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase. Hum Mol Genet 19 563-572.

Boyle JJ, Johns M, Kampfer T, Nguyen AT, Game L, Schaer DJ, Mason JC & Haskard DO 2012 Activating Transcription Factor 1 Directs Mhem Atheroprotective Macrophages Through Coordinated Iron Handling and Foam Cell Protection Circ Research 110 20-33.

Bultel-Brienne S, Lestavel S, Pilon A, Laffont I, Tailleux A, Fruchart JC, Siest G & Clavey V 2002 Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins. J Biol Chem 277 36092-36099.

Buonamici S, Chakraborty S, Senyuk V & Nucifora G 2003 The role of EVI1 in normal and leukemic cells. Blood Cells Mol Dis 31 206-212.

Calvo D, Dopazo J, & Vega MA 1995 The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution. Genomics 25 100-106.

Carrasco-Marín E, Fernández-Prieto L, Rodriguez-Del Rio E, Madrazo-Toca F, Reinheckel T, Saftig P & Alvarez-Dominguez C 2011 LIMP-2 links late phagosomal trafficking with the onset of the innate immune response to Listeria monocytogenes: a role in macrophage activation. J Biol Chem 286 3332-3341.

Chaves J, Beirão I, Balreira A, Gaspar P, Caiola D, Sá-Miranda MC & Lima JL 2011 Progressive myoclonus epilepsy with nephropathy C1q due to SCARB2/LIMP-2 deficiency: clinical report of two siblings. Seizure 20 738-740.

Coleman MD, Bass RB, Mehan RS & Falke JJ 2005 Conserved glycine residues in the cytoplasmic domain of the aspartate receptor play essential roles in kinase coupling and on-off switching. Biochem 44 7687-7695.

Collot-Teixeira S, Martin J, McDermott-Roe C, Poston R & McGregor JL 2007 CD36 and macrophages in atherosclerosis. Cardiovasc Res 75 468-477.

Connelly MA & Williams DL 2004 Scavenger receptor BI: A scavenger receptor with a mission to transport high density lipoprotein lipids. Curr Opinion Lipid 5 287-295.

Crombie R & Silverstein R 1998 Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif. J Biol Chem 273 4855-4863.

Desmond MJ, Lee D, Fraser SA, Katerelos M, Gleich K, Martinello P, Li YQ, Thomas MC, Michelucci R, Cole AJ, Saftig P, Schwake M, Stapleton D, Berkovic SF & Power DA 2011 Tubular proteinuria in mice and humans lacking the intrinsic lysosomal protein SCARB2/Limp-2. Am J Physiol Renal Physiol 300 F1437-1447.

Dibbens LM, Karakis I, Bayly MA, Costello DJ, Cole AJ & Berkovic SF 2011 Mutation of SCARB2 in a patient with progressive myoclonus epilepsy and demyelinating peripheral neuropathy. Arch Neurol 68 812-813.

Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A & Eriksson N 2011 Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 7 e1002141.

Donoghue PCJ & Benton MJ 2007 Rocks and clocks: calibrating the tree of life using fossils and molecules. Trends Genet 22 424-431.

Elango N & Yi SV 2011 Functional relevance of CpG island length for regulation of gene expression. Genetics 187 1077-1083.

Felsenstein J 1986 Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39 783-789.

Fujita H, Takata Y, Kono A, Tanaka Y, Takahashi T, Himeno M & Kato K 1992 Isolation and sequencing of a cDNA clone encoding the 85 kDa human lysosomal sialoglycoprotein (hLGP85) in human metastatic pancreas islet tumor cells. Biochem Biophys Res Commun 184 604-611.

Gaidukov L, Nager AR, Xu S, Penman M & Krieger M 2011 Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport. J Biol Chem 286 18452-18464.

Gamp AC, Tanaka Y, Lüllmann-Rauch R, Wittke D, D'Hooge R, De Deyn PP, Moser T, Maier H, Hartmann D, Reiss K, Illert AL, von Figura K & Saftig P 2003 LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum Mol Genet 12 631-646.

Gautam S & Banerjee M 2011 The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus. Mol Genet Metab 102 389-398.

Gupta R & Brunak S 2002 Prediction of glycosylation across the human proteome and the correlation to protein function. Pac Symp Biocomput 7 310-322.

Hall TA 1999 BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser 41 95-99.

Holmes RS 2012 Vertebrate patatin-like phospholipase domain-containing protein 4 (PNPLA4) genes and proteins: a gene with a role in retinol metabolism. 3 Biotech doi:10.1007/s13205-012-0063-7.

Holmes RS & Cox LA 2012 Comparative studies of vertebrate scavenger receptor class B type 1 (SCARB1): a high density lipoprotein (HDL) binding protein. Res. Reports Biochem 2 1016.

Holz A, Kollmus H, Ryge J, Niederkofler V, Dias J, Ericson J, Stoeckli ET, Kiehn O & Arnold HH 2010 The transcription factors Nkx2.2 and Nkx2.9 play a novel role in floor plate development and commissural axon guidance. Development 137 4249-4260.

Höning S, Griffith J, Geuze HJ & Hunziker W 1996 The tyrosine-based lysosomal targeting signal in lamp-1 mediates sorting into Golgi-derived clathrin-coated vesicles. EMBO J 15 5230-5239.

Hopfner F, Schormair B, Knauf F, Berthele A, Tölle TR, Baron R, Maier C, Treede RD, Binder A, Sommer C, Maihöfner C, Kunz W, Zimprich F, Heemann U, Pfeufer A, Näbauer M, Kääb S, Nowak B, Gieger C, Lichtner P, Trenkwalder C, Oexle K & Winkelmann J 2011 Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features. BMC Neurol 11 134.

Hunziker W & Geuze HJ 1996 Intracellular trafficking of lysosomal membrane proteins. Bioessays 18 379-389.

IIu I, Vorsanova SG, Saprina EA & IuB I 2010 Identification of candidate genes of autism on the basis of molecular cytogenetic and in silico studies of the genome organization of chromosomal regions involved in unbalanced rearrangements. Genetika 46 1348-1351.

James DE, Strube M & Mueckler M 1989 Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338 83-87.

Kamijo Y, Hora K, Tanaka N, Usuda N, Kiyosawa K, Nakajima T, Gonzalez FJ & Aoyama T 2002 Identification of functions of peroxisome proliferator-activated receptor alpha in proximal tubules. J Am Soc Nephrol 13 1691-1702.

Kay BK, Williamson MP & Sudol M 2000 The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 14 231-241.

Kent AP & Stylianou IM 2011 Scavenger receptor class B member 1 protein: hepatic regulation and its effects on lipids, reverse cholesterol transport, and atherosclerosis. Hep Med: Evid Res 3 29-44.

Kent WJ, Sugnet CW & Furey TS 2003 The human genome browser at UCSC. Genome Res 12 994-1006.

Kim CS, Hwang CK, Choi HS, Song KY, Law PY, Wei LN & Loh HH 2004 Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J Biol Chem 279 46464-46473.

Kim JW, Zhao SH, Uthe JJ, Bearson SM & Tuggle CK 2006 Assignment of the scavenger receptor class B, member 2 gene (SCARB2) to porcine chromosome 8q11-->q12 by somatic cell and radiation hybrid panel mapping. Cytogenet Genome Res 112 342H.

Krieger A, Möglich A & Kiefhaber T 2005 Effect of proline and glycine residues on dynamics and barriers of loop formation in polypeptide F. J Am Chem Soc 127 3346-3352.

Kuronita T, Eskelinen EL, Fujita H, Saftig P, Himeno M & Tanaka Y 2002 A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J Cell Sci 115 4117-4131.

Lauzier B, Merlen C, Vaillant F, McDuff J, Bouchard B, Beguin PC, Dolinsky VW, Foisy S, Villeneuve LR, Labarthe F, Dyck JR, Allen BG, Charron G & Des Rosiers C 2011 Post-translational modifications, a key process in CD36 function: lessons from the spontaneously hypertensive rat heart. J Mol Cell Cardiol 51 99-108.

Lewandrowski U, Moebius J, Walter U & Sickmann A 2006 Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. Mol Cell Proteomics 5 226-233.

Lin YW, Lin HY, Tsou YL, Chitra E, Hsiao KN, Shao HY, Liu CC, Sia C, Chong P & Chow YH 2012 Human SCARB2-Mediated Entry and Endocytosis of EV71. PLoS One 7 e30507.

MacArthur MW & Thornton JM 1991 Influence of proline residues on protein conformation. J Mol Biol 218 397-412.

Marsche G, Zimmermann R, Horiuchi S, Tandon NN, Sattler W & Malle E 2003 Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein. J Biol Chem 278 47562-47570.

Martin CA, Longman E, Wooding C, Hoosdally SJ, Ali S, Aitman TJ, Gutmann DA, Freemont PS, Byrne B & Linton KJ 2007 Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteins. Protein Sci 16 2531-2541.

McGuffin LJ, Bryson K & Jones DT 2000 The PSIPRED protein structure prediction server. Bioinform 16 404-405.

Michelakakis H, Xiromerisiou G, Dardiotis E, Bozi M, Vassilatis D, Kountra PM, Patramani G, Moraitou M, Papadimitriou D, Stamboulis E, Stefanis L, Zintzaras E & Hadjigeorgiou GM 2012 Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease. Mov Disord doi: 10.1002/mds.24886.

Nichols Z & Vogt RG 2008 The SNMP/CD36 gene family in Diptera, Hymenoptera and Coleoptera: Drosophila melanogaster, D. pseudoobscura, Anopheles gambiae, Aedes aegypti, Apis mellifera, and Tribolium castaneum. Insect Biochem Mol Biol 38 398-415.

Ogata S & Fukuda M 1994 Lysosomal targeting of Limp II membrane glycoprotein requires a novel Leu-Ile motif at a particular position in its cytoplasmic tail. J Biol Chem 269 5210-5217.

Papale GA, Hanson PJ & Sahoo D 2011 Extracellular disulfide bonds support scavenger receptor class B type I-mediated cholesterol transport. Biochem 50 6245-6254.

Rasmussen JT, Berglund L, Rasmussen MS & Petersen TE 1998 Assignment of disulfide bridges in bovine CD36. Eur J Biochem 257 488-494.

Reczek D, Schwake M, Schröder J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T & Saftig P 2007 LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell 131 770-783.

Ren Y 2012 Peroxisome proliferator-activator receptor γ: a link between macrophage CD36 and inflammation in malaria infection. PPAR Res 2012 640769.

Riley P, Anson-Cartwright L & Cross JC 1998 The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat Genet 18 271-275.

Roszek K & Gniot-Szulzycka J 2005 Lysosomal membrane glycoprotein lamp2a--receptor for chaperone-mediated degradation of cytosolic proteins. Postepy Biochem 51 88-94.

Rubboli G, Franceschetti S, Berkovic SF, Canafoglia L, Gambardella A, Dibbens LM, Riguzzi P, Campieri C, Magaudda A, Tassinari CA & Michelucci R 2011 Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations. Epilepsia 52 2356-2363.

Salaun C, Greaves J & Chamberlain LH 2010 The intracellular dynamic of protein palmitoylation. J Cell Biol 191 1229-1238.

Salem M, Mony JT, Løbner M, Khorooshi R & Owens T 2011 Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in mice. J Neuroinflammation 8 181.

Sandoval IV, Martinez-Arca S, Valdueza J, Palacios S & Holman GD 2000 Distinct reading of different structural determinants modulates the dileucine-mediated transport steps of the lysosomal membrane protein LIMPII and the insulin-sensitive glucose transporter GLUT4. J Biol Chem 275 39874-39885.

Saxonov S, Berg P & Brutlag DL 2006 A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci USA 103 1412-1417.

Schroen B, Leenders JJ, van Erk A, Bertrand AT, van Loon M, van Leeuwen RE, Kubben N, Duisters RF, Schellings MW, Janssen BJ, Debets JJ, Schwake M, Høydal MA, Heymans S, Saftig P & Pinto YM 2007 Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy. J Exp Med 204 1227-1235.

Simantov R & Silverstein RL 2003 CD36: a critical anti-angiogenic receptor. Front Biosci 8 s874-882.

Sleat DE, Zheng H, Qian M & Lobel P 2006 Identification of sites of mannose 6-phosphorylation on lysosomal proteins. Mol Cell Prot 5 686-701.

Su AI, Wiltshire T, Batalov S, Lapp H, Ching KR, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR & Hogenesch JB 2004 A gene atlas of the human and mouse protein encoding transcriptomes. Proc Natl Acad Sci USA 101 6062-6067.

Tandon NN, Lipsky RH, Burgess WH & Jamieson GA 1989 Isolation and characterization of platelet glycoprotein IV (CD36). J Biol Chem 264 7570-7575.

Tabuchi N, Akasaki K, Sasaki T, Kanda N &Tsuji H 1997 Identification and characterization of a major lysosomal membrane glycoprotein, LGP85/LIMP II in mouse liver. J Biochem 122 756-763.

Tabuchi N, Akasaki K & Tsuji H 2000 Two acidic amino acid residues, Asp(470) and Glu(471), contained in the carboxyl cytoplasmic tail of a major lysosomal membrane protein, LGP85/LIMP II, are important for its accumulation in secondary lysosomes. Biochem Biophys Res Commun 270 557-563.

Tabuchi N, Akasaki K & Tsuji H 2002 Ile (476), a constituent of di-leucine-based motif of a major lysosomal membrane protein, LGP85/LIMP II, is important for its proper distribution in late endosomes and lysosomes. Biochem Biophys Res Commun 295 149-156.

Tao N, Wagner SJ & Lublin DM 1996 CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails. J Biol Chem 271 22315-22320.

Thierry-Mieg D & Thierry-Mieg J 2006 AceView: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 S12.

Tserentsoodol N, Gordiyenko NV, Pascual I, Lee JW, Fliesler SJ & Rodriguez IR 2006 Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol Vis 12 1319-1333.

Velayati A, DePaolo J, Gupta N, Choi JH, Moaven N, Westbroek W, Goker-Alpan O, Goldin E, Stubblefield BK, Kolodny E, Tayebi N & Sidransky E 2011 A mutation in SCARB2 is a modifier in Gaucher disease. Hum Mutat 32 1232-1238.

Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T & Koike S 2009 Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15 798-801.

Yamayoshi S & Koike S 2011 Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol 85 4937-4946.

Yua M, Romera KA, Nielanda TJF, Xua S, Saenz-Vashb V, Penmana M, Yesilaltaya A, Carrb SA & Kriegera M 2011 Exoplasmic cysteine Cys384 of the HDL receptor SR-BI is critical for its sensitivity to a small-molecule inhibitor and normal lipid transport activity. Proc Natl Acad Sci USA 108 12243–12248.

Zhang X, Moor AN, Merkler KA, Liu Q & McLean MP 2007 Regulation of alternative splicing of liver scavenger receptor class B gene by estrogen and the involved regulatory splicing factors. Endocrinology 148 5295-5304.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Copyright © 2018 Lorem Ipsum Press